Advertisement

Topics

Achillion reports on interim data for factor D inhibitor candidate for PNH

05:00 EDT 10 Aug 2017 | SmartBrief

Interim data from Achillion Pharmaceuticals' Phase II trial evaluating the effectiveness of its factor D inhibitor candidate  -More

Original Article: Achillion reports on interim data for factor D inhibitor candidate for PNH

NEXT ARTICLE

More From BioPortfolio on "Achillion reports on interim data for factor D inhibitor candidate for PNH"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...